However, the most dominant ALK genomic alterations in cancer are caused by chromosomal rearrangement when different fusion partners and their associated promoter regions fuse the upstream of the ALK kinase domain leading to constitutive activation of ALK and the downstream PI3K/Akt and MAPK/Erk pathways. This evidence concerns the gene ALK and cancer.